Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Catasys Launches OnTrak™ Facebook Page

Catasys Health - Monday, January 04, 2010
Check out our new Catasys Health Facebook Recovery Network http://www.facebook.com/stayontrak. Also, don't forget to Like our Facebook Health Care Page.

Social Media Philosophy - Lead the social media revolution in Substance Dependence and Behavioral Health Care, contributing to health and well being for families and friends everywhere.

 » More


Cutting Edge Treatment for Substance Dependence for Health Plans

Catasys Health - Wednesday, December 16, 2009
For every 1 million members in a health plan, approximately $160 million in claims are incurred by members diagnosed with Substance Dependence. Most health plans have realistic cost savings opportunities in the millions of dollars. Our Medical Economics group can demonstrate specific savings opportunities for health plans with respect to both medical and behavioral costs.

The OnTrak program addresses many of the challenges experts highlight within the existing treatment paradigm for substance dependence. Specifically, OnTrak» More

Changing the Paradigm of Substance Dependent Treatment

Catasys Health - Wednesday, December 02, 2009

How OnTrak is Different - We function as a provider in your network and your MBHO’s network, complementing your existing delivery system. We go much deeper than your current programs to address the uniquely difficult needs of your high-utilizing substance dependent members. » More



Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More





| 1 |

 

 
  Tags
 
chronic pain heroin randomized OnTrak cocaine opioid overdose hospitalizations urine drug screen stress opiod-based double-blind codeine psychosocial prometa drug treatment cocaine treatment smoking relapse prevention opioid abuse naloxone suboxone contract reduction in craving alcoholism primary care stimulants depression gabapentin substance use disorder placebo predictive modeling drug addicts Journal of Psychopharmacology high-utilizing Opioid Treatment behavioral healthcare services depression screening cigarettes emergency room Raymond Anton pain killers dependence issues binge drinking opioid fentanyl percocet sobriety Opioid Medications recovery network drinking craving score addiction treatment treatment alcohol overdose sugar hospital Health Care Utilization oxycodone medical costs SD members methadone mental health behavioral health recovery post-traumatic stress disorder withdrawal Research Across America behavioral health care behavioral health care services flumazenil diabetes communication substance dependence reducing craving anxiety opiod abuse drug addiction Harold Urschel health insurance CIWA vicodin substance dependence health insurance OxyContin nicotine sober addiction stratified Catasys physician- patient relations identification behavioral healthcare placebo-controlled medical and behavioral costs morphine opioid antagonist social network meth ER craving care coaching data mining over-the-counter substances reduction in use facebook vivitrol mental illness painkillers health plan opioid-drug interactions marijuana substance dependence costs addict medical prescriptions ADHD drug abuse relapse buprenorphine PTSD pain pills trauma hydrocodone pain medication alcohol dependence Co Occurring Disorders drug use ADD opiates UnitedHealthcare narcotic SD health insurance health reform methamphetamine alcohol treatment bipolar disorder muscle relaxant methamphetamine dependence alcohol drinking
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025